Avid Bioservices Inc (CDMO)

[Protector]

investingdog, you missed something here:

One would expect that any chemo lung cancer treatment should work better as a first line treatment for the same reason - healthier patients.

First line SOC works better then second line SOC because first line SOC proved that. What you say would only be true of second line SOC would NEVER have competed in the first line arena. If it did it got equally healthy patients as the current first line SOC and hence must have lost the battle.

So yes, in this case 1st ln SOC works better then 2nd ln SOC.

15-25% improvement is good for me. it is a matter of appreciation. We are talking about one of the most deathliest cancers. 50% would be VERY good and all above super!

I put my expectation on good (as in sufficient for PIII design approval combined with safety profile) and hope for very good and will drink another bottle of champagne standing on my head if they are super.

So, if the results are good I'll be here to sheer you'all up because I will not be disappointed while many of you with to high expectation may be. The other way around someone of you may have to help me back on my feed with all that champagne :)